Risk factors for mortality in children with Candidemia

Pediatric Infectious Disease Journal

Volumn 24, Issue 8, 2005, Pages 736-739

  Zaoutis, Theoklis E ^a,d   Coffin, Susan E ^a   Chu, Jaclyn H ^a   Heydon, Kateri ^a   Zhao, Huaqing ^a   Greves, H Mollie ^b   Walsh, Thomas J ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Candidemia; Fungal infections; Invasive candidiasis; Mortality; Pediatric

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE;

ADOLESCENT; ARTERY CATHETERIZATION; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CHILD; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 23744504428     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000172938.76561.8e     Document Type: Article

References (12)

1. Hosteller MK. New insights into candidal infections. Adv Pediatr. 1996;43:209-230.
2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239-244.
3. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319-324.
4. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis. 1995;20:571-575.
5. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis. 1998;26:642-645.
6. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634-643.
7. Rodriguez-Nunez A. Incidence and mortality of proven invasive Candida infections in pediatric intensive care patients. Infect Control Hosp Epidemiol. 2001;22:477-478.
8. Turner RB, Donowitz LG, Hendley JO. Consequences of candidemia for pediatric patients. Am J Dis Child. 1985;139:178-180.
9. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167:695-701.
10. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004;23:635-641.
11. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis: Infectious Diseases Society of America. Clin Infect Dis. 2000;30:662-678.
12. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433-1437.